Home Infusion Therapy Market

Home Infusion Therapy Market

  • HC-4334
  • 4.2 Rating
  • 199 Pages
  • Upcoming
  • 76 Reviews
  • PDF Excel PPT
raksha

Author:

Raksha Sharma

Vineet

Fact-checked by:

Vineet Pandey

Shreyas

Editor:

Shreyas Tandon

The global home infusion therapy market size was valued at USD 31.4 billion in 2020 and is expected to expand at a CAGR of 6.9% during the forecast period, 2021–2028. The growth of the market is attributed to the increased infusion device demand and rising healthcare spending throughout the world.

Home Infusion Therapy Market summary

Home infusion therapy is a therapeutic method in which patients are treated at home using catheters and needles to administer medications or biologicals. Immune deficiencies, cancer, and congestive heart failure are among the ailments that cannot be treated with oral drugs and infusion therapy is a means for the treatment of these diseases. Since many patients require long-term care, the therapy is widely accepted to be a more cost-effective option than inpatient treatment. The Cancer Care at Home program was launched in February 2020 by the Penn Center for Cancer Care Innovation at the University of Pennsylvania's Abramson Cancer Center to expand the availability of cancer therapies to patients at home. As per the source, the number of patients participating in the program rose to 700% from mid-March to late April.

The pandemic of COVID-19 had caused positive impact on the home infusion therapy market since the method of home infusion was the need of the hour as healthcare facilities were overburdened with COVID patients. The regional and national lockdowns had adverse impact on operations and supply chains but the market in 2020 grew tremendously. According to Medtech Dive, Baxter announced third-quarter sales of USD 2.97 billion in October 2020, up 4% from the previous year due to increased demand for COVID-related medical devices. Several individuals were hospitalized as a result of the COVID-19 pandemic and several of them had to be put on ventilators.

Market Trends, Drivers, Restraints, and Opportunities

  • Patients’ preference for home setting treatment rather than in hospitals or healthcare facilities presents a key factor driving the market.
  • Rising number of patients suffering from chronic illness and lack of enough space and beds in hospitals for patients is another factor that propels the market.
  • Growing number of the older population who usually has lower mobility profile and their expanding desire for advanced home care settings are projected to fuel the market in the coming years.
  • As the number of hospital-acquired infections rises, so does the demand for home infusion therapy. This is expected to boost the market during the forecast period.
  • Product recalls and a complex reimbursement framework are major challenges that can hamper the market expansion during the forecast period.
  • Rapid technological advancement and presence of advanced medical facilities in hospitals are likely to create lucrative opportunities for the market growth during the given timeline.

Scope of the Report

The report on the global home infusion therapy market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Home Infusion Therapy Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Applications (Hydration Therapy [Athletes and Others], Endocrinology [Diabetes and Others], Parenteral Nutrition, Specialty Pharmaceuticals, Chemotherapy, Enteral Nutrition, Anti-infective, and Others), and Products (Infusion Pumps [Gravity, Electromechanical, Elastomeric, and Others], Ambulatory Infusion Pumps, IV Cannulas, Needleless Connectors, and Intravenous Sets)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

PharMerica; Fresenius Kabi; ICU Medical, Inc.; B. Braun Melsungen AG; Baxter; BD; Caesarea Medical Electronics; Smiths Medical; Terumo Corporation; JMS Co. Ltd.; CVS/Coram; Option Care Health; and BriovaRx/Diplomat (UnitedHealth Optum)

Market Segment Insights

Anti-infective segment to expand at a considerable CAGR

On the basis of applications, the home infusion therapy market is segmented into hydration therapy, endocrinology, parenteral nutrition, specialty pharmaceuticals, chemotherapy, enteral nutrition, anti-infective, and others. The hydration therapy segment is further bifurcated into athletes and others while the endocrinology segment is further categorized as diabetes and others. The anti-infective segment is projected to expand at a considerable CAGR during the forecast period as it aids in the reduction of patient exposure to other hospital-acquired illnesses. On the other hand, the chemotherapy segment is anticipated to account for a major market share during the forecast period due to the rising incidence of cancer. Chemotherapy pumps for home usage are small and continuous-pressure pumps that do not require a battery and, thus, can be used for extended periods of time.

Home Infusion Therapy Market applications

Infusion pumps segment to hold a significant share of the market

In terms of products, the market is divided into infusion pumps, ambulatory infusion pumps, IV cannulas, needleless connectors, and intravenous sets. The infusion pumps segment is further fragmented as gravity, electromechanical, elastomeric, and others. The infusion pumps segment is expected to hold a significant share of the market ascribed to rising demand for these pumps for delivering nourishment and drugs. However, the ambulatory infusion pumps segment is anticipated to account for a significant market share due to the rising popularity of home healthcare. Smart pumps are becoming popular because they have modern features such as barcode technology, which aids in the authentication of a patient's identification and prevents drug administration problems.

North America is anticipated to constitute a key market share

In terms of regions, the home infusion therapy market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a key share of the market during the projected period owing to the growing R&D and increased usage of new infusion pump technologies. However, the market of Asia Pacific is anticipated to expand at a rapid pace during the forecast period due to increased patient knowledge of the advantages of home infusion treatment versus in-hospital procedures as well as the region's rising diabetes incidence among a large number of the population.

Home Infusion Therapy Market regions

Segments

The global home infusion therapy market has been segmented on the basis of
Applications

  • Hydration Therapy
    • Athletes
    • Others
  • Endocrinology
    • Diabetes
    • Others
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Chemotherapy
  • Enteral Nutrition
  • Anti-infective
  • Others

Products

  • Infusion Pumps
    • Gravity
    • Electromechanical
    • Elastomeric
    • Others
  • Ambulatory Infusion Pumps
  • IV Cannulas
  • Needleless Connectors
  • Intravenous Sets

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • PharMerica
  • Fresenius Kabi
  • ICU Medical, Inc.
  • B. Braun Melsungen AG
  • Baxter
  • BD
  • Caesarea Medical Electronics
  • Smiths Medical
  • Terumo Corporation
  • JMS Co. Ltd.
  • CVS/Coram
  • Option Care Health
  • BriovaRx/Diplomat (UnitedHealth Optum)

Competitive Landscape

Key players competing in the global home infusion therapy market are PharMerica; Fresenius Kabi; ICU Medical, Inc.; B. Braun Melsungen AG; Baxter; BD; Caesarea Medical Electronics; Smiths Medical; Terumo Corporation; JMS Co. Ltd.; CVS/Coram; Option Care Health; and BriovaRx/Diplomat (UnitedHealth Optum).

Some of these key players often use methods including mergers, acquisitions, and new product releases to maintain market share and diversify their product portfolio. Hillrom was acquired by Baxter International in December of 2021 with an aim in expanding its global reach and integrating medical device technologies. Smiths Medical and Ivenix, Inc. established a partnership in May 2021 to provide a full portfolio of infusion management solutions in the United States market. This collaboration was intended to increase patient safety through evolving infusion management.

Home Infusion Therapy Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Home Infusion Therapy Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Home Infusion Therapy Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Home Infusion Therapy Market - Supply Chain
  4.5. Global Home Infusion Therapy Market Forecast
     4.5.1. Home Infusion Therapy Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Home Infusion Therapy Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Home Infusion Therapy Market Absolute $ Opportunity
5. Global Home Infusion Therapy Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Home Infusion Therapy Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Home Infusion Therapy Demand Share Forecast, 2019-2026
6. North America Home Infusion Therapy Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Home Infusion Therapy Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Home Infusion Therapy Demand Share Forecast, 2019-2026
7. Latin America Home Infusion Therapy Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Home Infusion Therapy Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Home Infusion Therapy Demand Share Forecast, 2019-2026
8. Europe Home Infusion Therapy Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Home Infusion Therapy Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Home Infusion Therapy Demand Share Forecast, 2019-2026
9. Asia Pacific Home Infusion Therapy Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Home Infusion Therapy Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Home Infusion Therapy Demand Share Forecast, 2019-2026
10. Middle East & Africa Home Infusion Therapy Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Home Infusion Therapy Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Home Infusion Therapy Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Home Infusion Therapy Market: Market Share Analysis
  11.2. Home Infusion Therapy Distributors and Customers
  11.3. Home Infusion Therapy Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. PharMerica
     11.4.2. Fresenius Kabi
     11.4.3. ICU Medical, Inc.
     11.4.4. B. Braun Melsungen AG
     11.4.5. Baxter
     11.4.6. BD
     11.4.7. Caesarea Medical Electronics
     11.4.8. Smiths Medical&

Purchase Premium Report